How many insider trades does FilingIQ track for TYRA?

FilingIQ tracks 253 Form 4 insider transactions for TYRA (Tyra Biosciences, Inc.), covering filings from Sep 17, 2021 onwards. 19 of those were filed in the last 90 days.

Are TYRA insiders net buyers or net sellers?

Across the full Form 4 history for TYRA, 14 transactions (6%) were open-market purchases and 134 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does TYRA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is TYRA in?

Tyra Biosciences, Inc. (TYRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

TYRA insider trading

Healthcare

Tyra Biosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

253

Last 90 days

Buys / sells

6% / 53%

Market cap

$1.49B

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.

Company website: tyra.bio

TYRA insider activity at a glance

FilingIQ has scored 253 insider transactions for TYRA since Sep 17, 2021. The most recent filing in our index is dated May 5, 2026.

Across the full history, 14 open-market purchases and 134 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on TYRA insider trades is 57.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live TYRA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding TYRA

Frazier Life Sciences Management, L.P.

$10.09M · 0.6% of AUM

Frequently asked

How many insider trades does FilingIQ track for TYRA?: FilingIQ tracks 253 Form 4 insider transactions for TYRA (Tyra Biosciences, Inc.), covering filings from Sep 17, 2021 onwards. 19 of those were filed in the last 90 days.
Are TYRA insiders net buyers or net sellers?: Across the full Form 4 history for TYRA, 14 transactions (6%) were open-market purchases and 134 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does TYRA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is TYRA in?: Tyra Biosciences, Inc. (TYRA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.49B.

Methodology & sources

Every TYRA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.